Pauley Celebrates a Record Year for Grants

Two large whiteboards grace Pauley’s clinical research offices in West Hospital. They are ledgers, located across the hallway from each other. One shows the status of new research studies in the process of being started; the other, details about active studies. Both ledgers are nearly filled.

“It looks like the arrivals and departures boards at an airport. When people come up here, they say, `Wow,’ because they usually don’t realize how much research is going on within the Division,” said Dr. Amy Ladd, research regulatory manager for clinical studies.

The whiteboards are a striking reminder of the success of the clinical research teams in attaining funding for their proposals—but there have been great achievements in basic and translational research as well. In 2018, Pauley celebrated a record-breaking year with $10,924,455 in grants—an increase of $2,841,592over 2017, including basic, translational and clinical research.

“I am excited to learn we had an amazing year for grants and so proud of our research teams. Our success comes at a time when research dollars are scarce, and funding is extremely competitive. Where we’re having growth is in industry-sponsored, society-based or federal research dollars,” said Director Dr. Greg Hundley.

Research areas driving the growth include inflammatory heart disease, cardio-oncology, cardiac sarcoidosis, heart failure and transplantation, diet-induced obesity and diabetes (including genetic mouse models) as they relate to cardiovascular disease and devices for electrophysiology applications.

“The funding enables us to develop and discover new therapies to treat disease. What this means, when you see these dollars going up, is that somebody thinks you’re doing a good job developing the therapies for the future,” said Hundley. “All of this would not be possible without the commitment of the entire team—from the PIs and the clinical research nurse coordinators to the individuals providing fiscal and regulatory oversight.”

“I am excited to learn we had an amazing year for grants and so proud of our research teams. Our success comes at a time when research dollars are scarce, and funding is extremely competitive. Where we’re having growth is in industry-sponsored, society-based or federal research dollars,” said Director Dr. Greg Hundley.